AU1353901A - Method of treating batten disease - Google Patents
Method of treating batten diseaseInfo
- Publication number
- AU1353901A AU1353901A AU13539/01A AU1353901A AU1353901A AU 1353901 A AU1353901 A AU 1353901A AU 13539/01 A AU13539/01 A AU 13539/01A AU 1353901 A AU1353901 A AU 1353901A AU 1353901 A AU1353901 A AU 1353901A
- Authority
- AU
- Australia
- Prior art keywords
- batten disease
- treating batten
- treating
- disease
- batten
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16828799P | 1999-12-01 | 1999-12-01 | |
US60168287 | 1999-12-01 | ||
PCT/US2000/029913 WO2001039760A2 (fr) | 1999-12-01 | 2000-10-30 | Methode de traitement de la maladie de batten |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1353901A true AU1353901A (en) | 2001-06-12 |
Family
ID=22610875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU13539/01A Abandoned AU1353901A (en) | 1999-12-01 | 2000-10-30 | Method of treating batten disease |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1353901A (fr) |
WO (1) | WO2001039760A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1688141A1 (fr) | 2005-01-31 | 2006-08-09 | elbion AG | Utilisation de flupirtine pour le traitement de la vessie hyperactive et des maladies associées et pour le traitement du syndrome du colon irritable |
DE102017007385A1 (de) | 2017-08-02 | 2019-02-07 | Christoph Hoock | Maleatfreie feste Arzneimittelformen |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4327516A1 (de) * | 1993-08-17 | 1995-02-23 | Asta Medica Ag | Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin |
DE19625582A1 (de) * | 1996-06-27 | 1998-01-02 | Asta Medica Ag | Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen |
-
2000
- 2000-10-30 WO PCT/US2000/029913 patent/WO2001039760A2/fr active Application Filing
- 2000-10-30 AU AU13539/01A patent/AU1353901A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001039760A2 (fr) | 2001-06-07 |
WO2001039760A3 (fr) | 2002-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2351661B (en) | Novel method of treatment | |
AU2001249881A1 (en) | Method of treating the heart | |
IL145875A0 (en) | Novel method of treatment | |
AU4063600A (en) | A method of treating cancer | |
AU2001240046A1 (en) | Method of treating skin conditions | |
AUPP870999A0 (en) | Method of treatment of equine disease | |
AU3009401A (en) | Method of treating fabrics | |
AU1353901A (en) | Method of treating batten disease | |
GB9930688D0 (en) | Novel method of treatment | |
AU4598400A (en) | Method of treatment | |
AU4985200A (en) | Methods of treating hypertension | |
AU2382601A (en) | Novel method of treatment | |
AU1108101A (en) | Method of treating plants | |
EP1135128A4 (fr) | Nouvelle methode therapeutique | |
AU1784701A (en) | Method of treating neuroblastoma | |
AU8031700A (en) | Method of treating fibrosis | |
GB9930696D0 (en) | Novel method of treatment | |
AU7923600A (en) | Method of treating fabric | |
AUPQ233299A0 (en) | Method of treatment | |
AUPQ080999A0 (en) | Method of treatment | |
AUPQ320299A0 (en) | Method of treatment | |
AUPP986699A0 (en) | Method of treating sugar | |
HUP0003249A3 (en) | Method of treating isolated systolic hypertension using eprosartan | |
AUPP363398A0 (en) | Method of treatment | |
AUPP795298A0 (en) | Method of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |